HOLVIANT Trademark

Trademark Overview


On Monday, August 26, 2013, a trademark application was filed for HOLVIANT with the United States Patent and Trademark Office. The USPTO has given the HOLVIANT trademark a serial number of 79136155. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, August 25, 2023. This trademark is owned by NOVARTIS AG. The HOLVIANT trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
holviant

General Information


Serial Number79136155
Word MarkHOLVIANT
Filing DateMonday, August 26, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, August 25, 2023
Registration Number4479510
Registration DateTuesday, February 11, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2013

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, March 24, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, March 24, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, March 8, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, March 8, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Thursday, April 3, 2014NOTIFICATION PROCESSED BY IB
Monday, March 17, 2014FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 17, 2014FINAL DISPOSITION PROCESSED
Thursday, March 13, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 11, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2013NOTIFICATION PROCESSED BY IB
Tuesday, November 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 13, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 6, 2013NOTICE OF PUBLICATION
Saturday, October 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 17, 2013ASSIGNED TO EXAMINER
Friday, October 4, 2013APPLICATION FILING RECEIPT MAILED
Monday, September 30, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 27, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords


holviant human vaccines